Viruses and multiple sclerosis

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 5, 2012, Pages 528-544

  Virtanen, Jussi Oskari ^a   Jacobson, Steve ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Epstein Barr virus; Human herpesvirus 6; Multiple sclerosis

Indexed keywords

ANTIVIRUS AGENT; EPITOPE; IMMUNOGLOBULIN G; OLIGOCLONAL BAND; VALACICLOVIR; VIRUS DNA;

ALLERGIC ENCEPHALOMYELITIS; BORNA DISEASE VIRUS; BRAIN DISEASE; CALLITRICHINAE; CELL DEATH; CEREBROSPINAL FLUID; CLINICAL STUDY; CORONAVIRUS; DEMYELINATION; DISEASE ASSOCIATION; EPITOPE MAPPING; EPSTEIN BARR VIRUS INFECTION; GENOME VIROME INTERACTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN HERPESVIRUS 6; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTIOUS MONONUCLEOSIS; JAPANESE MACAQUE ENCEPHALOMYELITIS; JC VIRUS; LYMPHOCYTIC INFILTRATION; MEASLES; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS ASSOCIATED AGENT; MURINE ENCEPHALOMYELITIS VIRUS; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PARAINFLUENZA VIRUS 1; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; POLYMERASE CHAIN REACTION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RABIES; RELAPSE; RETROVIRUS; REVIEW; SCRAPIE AGENT; SEROEPIDEMIOLOGY; SEROPREVALENCE; SIMIAN PARAINFLUENZA VIRUS 5; SIMON LIKE VIRUS; SUBACUTE SCLEROSING PANCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TORQUE TENO VIRUS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS REACTIVATION;

EID: 84863898426     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712801661220     Document Type: Review

References (176)

1. Ahlgren, C.; Oden, A.; Toren, K.; Andersen, O. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol. Scand., 2009, 119, 313-320.
2. Baranzini, S.E.; Mudge, J.; van Velkinburgh, J.C.; Khankhanian, P.; Khrebtukova, I.; Miller, N.A.; Zhang, L.; Farmer, A.D.; Bell, C.J.; Kim, R.W.; May, G.D.; Woodward, J.E.; Caillier, S.J.; McElroy, J.P.; Gomez, R.; Pando, M.J.; Clendenen, L.E.; Ganusova, E.E.; Schilkey, F.D.; Ramaraj, T.; Khan, O.A.; Huntley, J.J.; Luo, S.; Kwok, P.Y.; Wu, T.D.; Schroth, G.P.; Oksenberg, J.R.; Hauser, S.L.; Kingsmore, S.F. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature, 2010, 464, 1351-1356.
3. Krone, B.; Grange, J.M. Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background? Autoimmune Dis., 2011, 2011, 708-750.
4. Isaacson, S.H.; Asher, D.M.; Godec, M.S.; Gibbs, C.J., Jr.; Gajdusek, D.C. Widespread, restricted low-level measles virus infection of brain in a case of subacute sclerosing panencephalitis. Acta Neuropathol., 1996, 91, 135-139.
5. Mutinelli, F.; Vandevelde, M.; Griot, C.; Richard, A. Astrocytic infection in canine distemper virus-induced demyelination. Acta Neuropathol., 1989, 77, 333-335.
6. Goodman, A.D.; Mock, D.J.; Powers, J.M.; Baker, J.V.; Blumberg, B.M. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J. Infect. Dis., 2003, 187, 1365-1376.
7. Challoner, P.B.; Smith, K.T.; Parker, J.D.; MacLeod, D.L.; Coulter, S.N.; Rose, T.M.; Schultz, E.R.; Bennett, J.L.; Garber, R.L.; Chang, M. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA, 1995, 92, 7440-7444.
8. Fujinami, R.S.; Oldstone, M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science, 1985, 230, 1043-1045.
9. Wucherpfennig, K.W.; Strominger, J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell, 1995, 80, 695-705.
10. Zhao, Z.S.; Granucci, F.; Yeh, L.; Schaffer, P.A.; Cantor, H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science, 1998, 279, 1344-1347.
11. Soldan, S.S.; Leist, T.P.; Juhng, K.N.; McFarland, H.F.; Jacobson, S. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann. Neurol., 2000, 47, 306-313.
12. Tejada-Simon, M.V.; Zang, Y.C.; Hong, J.; Rivera, V.M.; Zhang, J.Z. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann. Neurol., 2003, 53, 189-197.
13. Cepok, S.; Zhou, D.; Srivastava, R.; Nessler, S.; Stei, S.; Bussow, K.; Sommer, N.; Hemmer, B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest., 2005, 115, 1352-1360.
14. Lunemann, J.D.; Edwards, N.; Muraro, P.A.; Hayashi, S.; Cohen, J.I.; Munz, C.; Martin, R. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain, 2006, 129, 1493-1506.
15. Jilek, S.; Schluep, M.; Meylan, P.; Vingerhoets, F.; Guignard, L.; Monney, A.; Kleeberg, J.; Le Goff, G.; Pantaleo, G.; Du Pasquier, R.A. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain, 2008, 131, 1712-1721.
16. Lunemann, J.D.; Jelcic, I.; Roberts, S.; Lutterotti, A.; Tackenberg, B.; Martin, R.; Münz, C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and coproduce IFN-gamma and IL-2. J. Exp. Med., 2008, 205, 1763-1773.
17. Gabibov, A.G.; Belogurov, A.A., Jr.; Lomakin, Y.A.; Zakharova, M.Y.; Avakyan, M.E.; Dubrovskaya, V.V.; Smirnov, I.V.; Ivanov, A.S.; Molnar, A.A.; Gurtsevitch, V.E.; Diduk, S.V.; Smirnova, K.V.; Avalle, B.; Sharanova, S.N.; Tramontano, A.; Friboulet, A.; Boyko, A.N.; Ponomarenko, N.A.; Tikunova, N.V. Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J., 2011, 25(12), 4211-4221.
18. Yu, X.; Gilden, D.H.; Ritchie, A.M.; Burgoon, M.P.; Keays, K.M.; Owens, G.P. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J. Neuroimmunol., 2006, 172, 121-131.
19. Lehmann, P.V.; Forsthuber, T.; Miller, A.; Sercarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature, 1992, 358, 155-157.
20. Vanderlugt, C.L.; Miller, S.D. Epitope spreading in immunemediated diseases: implications for immunotherapy. Nat. Rev. Immunol., 2002, 2, 85-95.
21. McRae, B.L.; Vanderlugt, C.L.; Dal Canto, M.C.; Miller, S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med., 1995, 182, 75-85.
22. Karpus, W.J.; Pope, J.G.; Peterson, J.D.; Dal Canto, M.C.; Miller, S.D. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol., 1995, 155, 947-957.
23. Miller, S.D.; Vanderlugt, C.L.; Begolka, W.S.; Pao, W.; Yauch, R.L.; Neville, K.L.; Katz-Levy, Y.; Carrizosa, A.; Kim, B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med., 1997, 3, 1133-1136.
24. Virgin, H.W.; Wherry, E.J.; Ahmed, R. Redefining chronic viral infection. Cell, 2009, 138, 30-50.
25. Lipton, H.L.; Liang, Z.; Hertzler, S.; Son, K.N. A specific viral cause of multiple sclerosis: one virus, one disease. Ann. Neurol., 2007, 61, 514-523.
26. Lucchinetti, C.; Bruck, W.; Parisi, J.; Scheithauer, B.; Rodriguez, M.; Lassmann, H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol., 2000, 47, 707-717.
27. Steiner, I.; Sriram, S. The "one virus, one disease" model of multiple sclerosis is too constraining. Ann. Neurol., 2007, 62, 529; author reply 529.
28. Foxman, E.F.; Iwasaki, A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat. Rev. Microbiol., 2011, 9, 254-264.
29. Thorley-Lawson, D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol., 2001, 1, 75-82.
30. Nikoskelainen, J.; Panelius, M.; Salmi, A. E.B. virus and multiple sclerosis. Br. Med. J., 1972, 4, 111.
31. Santiago, O.; Gutierrez, J.; Sorlozano, A.; de Dios Luna, J.; Villegas, E.; Fernandez, O. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur. J. Clin. Microbiol. Infect. Dis., 2010, 29, 857-866.
32. Castellazzi, M.; Tamborino, C.; Cani, A.; Negri, E.; Baldi, E.; Seraceni, S.; Tola, M.R.; Granieri, E.; Contini, C.; Fainardi, E. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult. Scler., 2010, 16, 883-887.
33. Otto, C.; Oltmann, A.; Stein, A.; Frenzel, K.; Schroeter, J.; Habbel, P.; Gärtner, B.; Hofmann, J.; Ruprecht, K. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology, 2011, 76, 1316-1321.
34. Lassmann, H.; Niedobitek, G.; Aloisi, F.; Middeldorp, J.M. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain, 2011, 134, 2772-2786.
35. Serafini, B.; Rosicarelli, B.; Franciotta, D.; Magliozzi, R.; Reynolds, R.; Cinque, P.; Andreoni, L.; Trivedi, P.; Salvetti, M.; Faggioni, A.; Aloisi, F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med., 2007, 204, 2899-2912.
36. Willis, S.N.; Stadelmann, C.; Rodig, S.J.; Caron, T.; Gattenloehner, S.; Mallozzi, S.S.; Roughan, J.E.; Almendinger, S.E.; Blewett, M.M.; Brück, W.; Hafler, D.A.; O'Connor, K.C. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain, 2009, 132, 3318-3328.
37. Handel, A.E.; Williamson, A.J.; Disanto, G.; Handunnetthi, L.; Giovannoni, G.; Ramagopalan, S.V. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One, 2010, 5.
38. Nielsen, T.R.; Rostgaard, K.; Askling, J.; Steffensen, R.; Oturai, A.; Jersild, C.; Koch-Henriksen, N.; Sørensen, P.S.; Hjalgrim, H. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult. Scler., 2009, 15, 431-436.
39. Nielsen, T.R.; Rostgaard, K.; Nielsen, N.M.; Koch-Henriksen, N.; Haahr, S.; Sorensen, P.S.; Hjalgrim, H. Multiple sclerosis after infectious mononucleosis. Arch. Neurol., 2007, 64, 72-75.
40. Ascherio, A.; Munger, K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol., 2007, 61, 288-299.
41. Wagner, H.J.; Munger, K.L.; Ascherio, A. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis. Eur. J. Neurol., 2004, 11, 833-834.
42. Hollsberg, P.; Kusk, M.; Bech, E.; Hansen, H.J.; Jakobsen, J.; Haahr, S. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity. Acta Neurol. Scand., 2005, 112, 395-402.
43. Sotelo, J.; Ordonez, G.; Pineda, B. Varicella-zoster virus at relapses of multiple sclerosis. J. Neurol., 2007, 254, 493-500.
44. Alvarez, R.; Cour, I.; Kanaan, A.; Benedicto, M.; Martin-Estefania, C.; Arroyo, R.; Varela de Seijas, E.; Picazo, J.J. Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR). Enferm. Infec. Microbiol. Clin., 2000, 18, 223-228.
45. Ferrante, P.; Mancuso, R.; Pagani, E.; Guerini, F.R.; Calvo, M.G.; Saresella, M.; Speciale, L.; Caputo, D. Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J. Neurovirol., 2000, 6(Suppl 2), S109-S114.
46. Hay, K.A.; Tenser, R.B. Leukotropic herpesviruses in multiple sclerosis. Mult. Scler., 2000, 6, 66-68.
47. Salahuddin, S.Z.; Ablashi, D.V.; Markham, P.D.; Josephs, S.F.; Sturzenegger, S.; Kaplan, M.; Kramarsky, B.; Markham, P.D.; Salahuddin, S.Z.; Sturzenegger, S.; Wong-Staal, F. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science, 1986, 234, 596-601.
48. De Bolle, L.; Naesens, L.; De Clercq, E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev., 2005, 18, 217-245.
49. Hall, C.B.; Caserta, M.T.; Schnabel, K.C.; Long, C.; Epstein, L.G.; Insel, R.A.; Dewhurst, S. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin. Infect. Dis., 1998, 26, 132-137.
50. Sola, P.; Merelli, E.; Marasca, R.; Poggi, M.; Luppi, M.; Montorsi, M.; Torelli, G. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J. Neurol. Neurosurg. Psychiatry, 1993, 56, 917-919.
51. Wilborn, F.; Schmidt, C.A.; Brinkmann, V.; Jendroska, K.; Oettle, H.; Siegert, W. A potential role for human herpesvirus type 6 in nervous system disease. J. Neuroimmunol., 1994, 49, 213-214.
52. Lisitsyn, N.; Lisitsyn, N.; Wigler, M. Cloning the differences between two complex genomes. Science, 1993, 259, 946-951.
53. Cermelli, C.; Berti, R.; Soldan, S.S.; Mayne, M.; D'Ambrosia, J.M.; Ludwin, S.K.; Jacobson, S. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J. Infect. Dis., 2003, 187, 1377-1387.
54. Carrigan, D.R.; Knox, K.K. Human herpesvirus six and multiple sclerosis. Mult. Scler., 1997, 3, 390-394.
55. Knox, K.K.; Brewer, J.H.; Henry, J.M.; Harrington, D.J.; Carrigan, D.R. Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin. Infect. Dis., 2000, 31, 894-903.
56. Friedman, J.E.; Lyons, M.J.; Cu, G.; Ablashl, D.V.; Whitman, J.E.; Edgar, M.; Koskiniemi, M.; Vaheri, A.; Zabriskie, J.B. The association of the human herpesvirus-6 and MS. Mult. Scler., 1999, 5, 355-362.
57. Virtanen, J.O.; Zabriskie, J.B.; Siren, V.; Friedman, J.E.; Lyons, M.J.; Edgar, M.; Vaheri, A.; Koskiniemi, M. Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med. Sci. Monit., 2005, 11, BR84-87.
58. Coates, A.R.; Bell, J. HHV-6 and multiple sclerosis. Nat. Med., 1998, 4, 537-538.
59. Edwards, S.; Zvartau, M.; Clarke, H.; Irving, W.; Blumhardt, L.D. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 1998, 64, 736-741.
60. Oikonen, M.; Laaksonen, M.; Aalto, V.; Ilonen, J.; Salonen, R.; Eralinna, J.P.; Panelius, M.; Salmi, A. Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence. Mult. Scler., 2011, 17, 672-680.
61. Buljevac, D.; Flach, H.Z.; Hop, W.C.; Hijdra, D.; Laman, J.D.; Savelkoul, H.F.; van Der Meché, F.G.; van Doorn, P.A.; Hintzen, R.Q. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain, 2002, 125, 952-960.
62. Sibley, W.A.; Bamford, C.R.; Clark, K. Clinical viral infections and multiple sclerosis. Lancet, 1985, 1, 1313-1315.
63. Confavreux, C.; Suissa, S.; Saddier, P.; Bourdes, V.; Vukusic, S. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N. Engl. J. Med., 2001, 344, 319-326.
64. Farez, M.F.; Correale, J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J. Neurol., 2011, 258, 1197-1206.
65. Berti, R.; Brennan, M.B.; Soldan, S.S.; Ohayon, J.M.; Casareto, L.; McFarland, H.F.; Jacobson, S. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J. Neurovirol., 2002, 8, 250-256.
66. Chapenko, S.; Millers, A.; Nora, Z.; Logina, I.; Kukaine, R.; Murovska, M. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol., 2003, 69, 111-117.
67. Alvarez-Lafuente, R.; De las Heras, V.; Bartolome, M.; Picazo, J.J.; Arroyo, R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch. Neurol., 2004, 61, 1523-1527.
68. Rotola, A.; Ravaioli, T.; Gonelli, A.; Dewhurst, S.; Cassai, E.; Di Luca, D. U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl. Acad. Sci. USA, 1998, 95, 13911-13916.
69. Barnes, D.W.; Whitley, R.J. CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy. Neurol. Clin., 1986, 4, 265-283.
70. Marrie, R.A.; Wolfson, C. Multiple sclerosis and varicella zoster virus infection: a review. Epidemiol. Infect., 2001, 127, 315-325.
71. Leinikki, P.; Shekarchi, I.; Iivanainen, M.; Taskinen, E.; Holmes, K.V.; Madden, D.; Sever, J.L. Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests. J. Neurol. Sci., 1982, 57, 249-255.
72. Forghani, B.; Cremer, N.E.; Johnson, K.P.; Fein, G.; Likosky, W.H. Comprehensive viral immunology of multiple sclerosis. III. Analysis of CSF antibodies by radioimmunoassay. Arch. Neurol., 1980, 37, 616-619.
73. Ordonez, G.; Pineda, B.; Garcia-Navarrete, R.; Sotelo, J. Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis. Arch. Neurol., 2004, 61, 529-532.
74. Sotelo, J.; Martinez-Palomo, A.; Ordonez, G.; Pineda, B. Varicellazoster virus in cerebrospinal fluid at relapses of multiple sclerosis. Ann. Neurol., 2008, 63, 303-311.
75. Burgoon, M.P.; Cohrs, R.J.; Bennett, J.L.; Anderson, S.W.; Ritchie, A.M.; Cepok, S.; Hemmer, B.; Gilden, D.; Owens, G.P. Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis. Ann. Neurol., 2009, 65, 474-479.
76. Kang, J.H.; Sheu, J.J.; Kao, S.; Lin, H.C. Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study. J. Infect. Dis., 2011, 204, 188-192.
77. Perron, H.; Bernard, C.; Bertrand, J.B.; Lang, A.B.; Popa, I.; Sanhadji, K.; Portoukalian, J. Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis. J. Neurol. Sci., 2009, 286, 65-72.
78. Perron, H.; Geny, C.; Laurent, A.; Mouriquand, C.; Pellat, J.; Perret, J.; Seigneurin, J.M. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res. Virol., 1989, 140, 551-561.
79. Koprowski, H.; DeFreitas, E.C.; Harper, M.E.; Sandberg-Wollheim, M.; Sheremata, W.A.; Robert-Guroff, M.; Saxinger, C.W.; Feinberg, M.B.; Wong-Staal, F.; Gallo, R.C. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature, 1985, 318, 154-160.
80. Haahr, S.; Sommerlund, M.; Christensen, T.; Jensen, A.W.; Hansen, H.J.; Moller-Larsen, A. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease. Ann. NY Acad. Sci., 1994, 724, 148-156.
81. Perron, H.; Gratacap, B.; Lalande, B.; Genoulaz, O.; Laurent, A.; Geny, C.; Mallaret, M.; Innocenti, P.; Schuller, E.; Stoebner, P.; Seignerurin, J.M. In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient. Res. Virol., 1992, 143, 337-350.
82. Perron, H.; Garson, J.A.; Bedin, F.; Beseme, F.; Paranhos-Baccala, G.; Komurian-Pradel, F.; Mallet, F.; Tuke, P.W.; Voisset, C.; Blond, J.L.; Lalande, B.; Seigneurin, J.M.; Mandrand, B. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc. Natl. Acad. Sci. USA, 1997, 94, 7583-7588.
83. Blond, J.L.; Beseme, F.; Duret, L.; Bouton, O.; Bedin, F.; Perron, H.; Mandrand, B.; Mallet, F. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol., 1999, 73, 1175-1185.
84. Garson, J.A.; Tuke, P.W.; Giraud, P.; Paranhos-Baccala, G.; Perron, H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet, 1998, 351, 33.
85. Sotgiu, S.; Serra, C.; Mameli, G.; Pugliatti, M.; Rosati, G.; Arru, G.; Dolei, A. Multiple sclerosis-associated retrovirus and MS prognosis: an observational study. Neurology, 2002, 59, 1071-1073.
86. Sotgiu, S.; Mameli, G.; Serra, C.; Zarbo, I.R.; Arru, G.; Dolei, A. Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult. Scler., 2010, 16, 1248-1251.
87. Bhat, R.K.; Ellestad, K.K.; Wheatley, B.M.; Warren, R.; Holt, R.A.; Power, C. Age-and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression. PLoS One, 2011, 6, e19176.
88. Antony, J.M.; van Marle, G.; Opii, W.; Butterfield, D.A.; Mallet, F.; Yong, V.W.; Wallace, J.L.; Deacon, R.M.; Warren, K.; Power, C. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci., 2004, 7, 1088-1095.
89. Rolland, A.; Jouvin-Marche, E.; Viret, C.; Faure, M.; Perron, H.; Marche, P.N. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J. Immunol., 2006, 176, 7636-7644.
90. Antony, J.M.; Ellestad, K.K.; Hammond, R.; Imaizumi, K.; Mallet, F.; Warren, K.G.; Power, C. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J. Immunol., 2007, 179, 1210-1224.
91. Adams, J.M. Measles antibodies in patients with multiple sclerosis. Neurology, 1967, 17, 707 passim.
92. Brankin, B.; Osman, M.; Herlihy, L.; Hawkins, S.A.; Cosby, S.L. Failure to detect measles virus RNA, by reverse transcriptionpolymerase chain reaction, in peripheral blood leucocytes of patients with multiple sclerosis. Mult. Scler., 1996, 1, 204-206.
93. Geeraedts, F.; Wilczak, N.; van Binnendijk, R.; De Keyser, J. Search for morbillivirus proteins in multiple sclerosis brain tissue. Neuroreport, 2004, 15, 27-32.
94. Ahlgren, C.; Oden, A.; Haghighi, S.; Andersen, O.; Bergstrom, T.; Lycke, J. The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome. J. Neuroimmunol., 2011, 235, 98-103.
95. Gilden, D.H. Viruses and multiple sclerosis. JAMA, 2001, 286, 3127-3129.
96. Yao, S.Y.; Stratton, C.W.; Mitchell, W.M.; Sriram, S. CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology, 2001, 56, 1168-1176.
97. Fainardi, E.; Castellazzi, M.; Tamborino, C.; Seraceni, S.; Tola, M.R.; Granieri, E.; Contini, C. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms. J. Neurovirol., 2009, 15, 425-433.
98. Franciotta, D.; Di Stefano, A.L.; Jarius, S.; Zardini, E.; Tavazzi, E.; Ballerini, C.; Marchioni, E.; Bergamaschi, R.; Ceroni, M. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases. J. Neuroimmunol., 2011, 230, 160-163.
99. Virtanen, J.O.; Pietilainen-Nicklen, J.; Uotila, L.; Farkkila, M.; Vaheri, A.; Koskiniemi, M. Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid. J. Neuroimmunol., 2011, 237, 93-97.
100. Piccio, L.; Naismith, R.T.; Trinkaus, K.; Klein, R.S.; Parks, B.J.; Lyons, J.A.; Cross, A.H. Changes in B-and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch. Neurol., 2010, 67, 707-714.
101. Hauser, S.L.; Waubant, E.; Arnold, D.L.; Vollmer, T.; Antel, J.; Fox, R.J.; Bar-Or, A.; Panzara, M.; Sarkar, N.; Agarwal, S.; Langer-Gould, A.; Smith, C.H.; HERMES Trial Group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med., 2008, 358, 676-688.
102. McRae, B.L.; Kennedy, M.K.; Tan, L.J.; Dal Canto, M.C.; Picha, K.S.; Miller, S.D. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol., 1992, 38, 229-240.
103. Barnett, L.A.; Whitton, J.L.; Wada, Y.; Fujinami, R.S. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol., 1993, 44, 15-25.
104. Pachner, A.R. Experimental models of multiple sclerosis. Curr. Opin. Neurol., 2011, 24, 291-299.
105. Axthelm, M.K.; Bourdette, D.N.; Marracci, G.H.; Su, W.; Mullaney, E.T.; Manoharan, M.; Kohama, S.G.; Pollaro, J.; Witkowski, E.; Wang, P.; Rooney, W.D.; Sherman, L.S.; Wong, S.W. Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate. Ann. Neurol., 2011, 70, 362-373.
106. t Hart, B.A.; Laman, J.D.; Bauer, J.; Blezer, E.; van Kooyk, Y.; Hintzen, R.Q. Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol., 2004, 3, 588-597.
107. Donati, D.; Akhyani, N.; Fogdell-Hahn, A.; Cermelli, C.; Cassiani-Ingoni, R.; Vortmeyer, A.; Heiss, J.D.; Cogen, P.; Gaillard, W.D.; Sato, S.; Theodore, W.H.; Jacobson, S. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology, 2003, 61, 1405-1411.
108. Fotheringham, J.; Donati, D.; Akhyani, N.; Fogdell-Hahn, A.; Vortmeyer, A.; Heiss, J.D.; Williams, E.; Weinstein, S.; Bruce, D.A.; Gaillard, W.D.; Sato, S.; Theodore, W.H.; Jacobson, S. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med., 2007, 4, e180.
109. Yao, K.; Honarmand, S.; Espinosa, A.; Akhyani, N.; Glaser, C.; Jacobson, S. Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis. Ann. Neurol., 2009, 65, 257-267.
110. Bech, E.; Lycke, J.; Gadeberg, P.; Hansen, H.J.; Malmestrom, C.; Andersen, O.; Christensen, T.; Ekholm, S.; Haahr, S.; Höllsberg, P.; Bergström, T.; Svennerholm, B.; Jakobsen, J. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology, 2002, 58, 31-36.
111. Friedman, J.E.; Zabriskie, J.B.; Plank, C.; Ablashi, D.; Whitman, J.; Shahan, B.; Edgell, R.; Shieh, M.; Rapalino, O.; Zimmerman, R.; Sheng, D. A randomized clinical trial of valacyclovir in multiple sclerosis. Mult. Scler., 2005, 11, 286-295.
112. Reymen, D.; Naesens, L.; Balzarini, J.; Holy, A.; Dvorakova, H.; De Clercq, E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res., 1995, 28, 343-357.
113. Goodman, A.D.; Miller, D.H. Infections and MS: clinical trials move to center stage. Neurology, 2002, 58, 7-8.
114. Whitley, R. The new age of molecular diagnostics for microbial agents. N. Engl. J. Med., 2008, 358, 988-989.
115. Wang, D.; Coscoy, L.; Zylberberg, M.; Avila, P.C.; Boushey, H.A.; Ganem, D.; DeRisi, J.L. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. USA, 2002, 99, 15687-15692.
116. Palacios, G.; Quan, P.L.; Jabado, O.J.; Conlan, S.; Hirschberg, D.L.; Liu, Y.; Zhai, J.; Renwick, N.; Hui, J.; Hegyi, H.; Grolla, A.; Strong, J.E.; Towner, J.S.; Geisbert, T.W.; Jahrling, P.B.; Büchen-Osmond, C.; Ellerbrok, H.; Sanchez-Seco, M.P.; Lussier, Y.; Formenty, P.; Nichol, M.S.; Feldmann, H.; Briese, T.; Lipkin, W.I. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg. Infect. Dis., 2007, 13, 73-81.
117. Palacios, G.; Druce, J.; Du, L.; Tran, T.; Birch, C.; Briese, T.; Conlan, S.; Quan, P.L.; Hui, J.; Marshall, J.; Simons, J.F.; Egholm, M.; Paddock, C.D.; Shieh, W.J.; Goldsmith, C.S.; Zaki, S.R.; Catton, M.; Lipkin, W.I. A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med., 2008, 358, 991-998.
118. Johnson, R.T. The virology of demyelinating diseases. Ann. Neurol., 1994, 36(Suppl), S54-S60.
119. Larsen, P.D.; Bloomer, L.C.; Bray, P.F. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology, 1985, 35, 435-438.
120. Wandinger, K.; Jabs, W.; Siekhaus, A.; Bubel, S.; Trillenberg, P.; Wagner, H.; Wessel, K.; Kirchner, H.; Hennig, H. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology, 2000, 55, 178-184.
121. Munch, M.; Riisom, K.; Christensen, T.; Moller-Larsen, A.; Haahr, S. The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients? Acta Neurol. Scand., 1998, 97, 171-174.
122. Pohl, D.; Krone, B.; Rostasy, K.; Kahler, E.; Brunner, E.; Lehnert, M.; Wagner, H.J.; Gärtner, J.; Hanefeld, F. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology, 2006, 67, 2063-2065.
123. Banwell, B.; Krupp, L.; Kennedy, J.; Tellier, R.; Tenembaum, S.; Ness, J.; Belman, A.; Boiko, A.; Bykova, O.; Waubant, E.; Mah, J.K.; Stoian, C.; Kremenchutzky, M.; Bardini, M.R.; Ruggieri, M.; Rensel, M.; Hahn, J.; Weinstock-Guttman, B.; Yeh, E.A.; Farrell, K.; Freedman, M.; Iivanainen, M.; Sevon, M.; Bhan, V.; Dilenge, M.E.; Stephens, D.; Bar-Or, A. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol., 2007, 6, 773-781.
124. Haahr, S.; Plesner, A.M.; Vestergaard, B.F.; Hollsberg, P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol. Scand., 2004, 109, 270-275.
125. Wagner, H.J.; Hennig, H.; Jabs, W.J.; Siekhaus, A.; Wessel, K.; Wandinger, K.P. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis. Viral Immunol., 2000, 13, 497-502.
126. Sundstrom, P.; Juto, P.; Wadell, G.; Hallmans, G.; Svenningsson, A.; Nystrom, L.; Dillner, J.; Forsgren, L. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology, 2004, 62, 2277-2282.
127. Lindsey, J.W.; Hatfield, L.M.; Vu, T. Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis. Eur. J. Neurol., 2010, 17, 1263-1269.
128. Ingram, G.; Bugert, J.J.; Loveless, S.; Robertson, N.P. Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity. Eur. J. Neurol., 17, 1386-1389.
129. Villegas, E.; Santiago, O.; Carrillo, J.A.; Sorlozano, A.; Guerrero, M.; Fernandez, O.; Gutiérrez, J. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients. Diagn. Microbiol. Infect. Dis., 70, 85-90.
130. Bray, P.F.; Luka, J.; Bray, P.F.; Culp, K.W.; Schlight, J.P. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology, 1992, 42, 1798-1804.
131. Zivadinov, R.; Nasuelli, D.; Tommasi, M.A.; Serafin, M.; Bratina, A.; Ukmar, M.; Pirko, I.; Johnson, A.J.; Furlan, C.; Pozzi-Mucelli, R.S.; Monti-Bragadin, L.; Grop, A.; Zambon, M.; Antonello, R.M.; Cazzato, G.; Zorzon, M. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol. Res., 2006, 28, 262-269.
132. Ponsonby, A.L.; van der Mei, I.; Dwyer, T.; Blizzard, L.; Taylor, B.; Kemp, A.; Simmons, R.; Kilpatrick, T. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA, 2005, 293, 463-469.
133. Alotaibi, S.; Kennedy, J.; Tellier, R.; Stephens, D.; Banwell, B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA, 2004, 291, 1875-1879.
134. Ascherio, A.; Munger, K.L.; Lennette, E.T.; Spiegelman, D.; Hernan, M.A.; Olek, M.J.; Hankinson, S.E.; Hunter, D.J. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA, 2001, 286, 3083-3088.
135. Myhr, K.M.; Riise, T.; Barrett-Connor, E.; Myrmel, H.; Vedeler, C.; Gronning, M.; Kalvenes, M.B.; Nyland, H. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J. Neurol. Neurosurg. Psychiatry, 1998, 64, 539-542.
136. Shirodaria, P.V.; Haire, M.; Fleming, E.; Merrett, J.D.; Hawkins, S.A.; Roberts, S.D. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch. Neurol., 1987, 44, 1237-1241.
137. Bray, P.F.; Bloomer, L.C.; Salmon, V.C.; Bagley, M.H.; Larsen, P.D. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch. Neurol., 1983, 40, 406-408.
138. Sumaya, C.V.; Myers, L.W.; Ellison, G.W. Epstein-Barr virus antibodies in multiple sclerosis. Arch. Neurol., 1980, 37, 94-96.
139. Sumaya, C.V.; Myers, L.; Ellison, G.W. Epstein-Barr virus antibodies in multiple sclerosis. Trans. Am. Neurol. Assoc., 1976, 101, 300-302.
140. Morre, S.A.; van Beek, J.; De Groot, C.J.; Killestein, J.; Meijer, C.J.; Polman, C.H.; van der Valk, P.; Middeldorp, J.M.; van Den Brule, A.J. Is Epstein-Barr virus present in the CNS of patients with MS? Neurology, 2001, 56, 692.
141. Sanders, V.J.; Felisan, S.; Waddell, A.; Tourtellotte, W.W. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J. Neurovirol., 1996, 2, 249-258.
142. Alvarez-Lafuente, R.; Garcia-Montojo, M.; De Las Heras, V.; Dominguez-Mozo, M.I.; Bartolome, M.; Benito-Martin, M.S.; Arroyo, R. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult. Scler., 2008, 14, 595-601.
143. Denne, C.; Kleines, M.; Dieckhofer, A.; Ritter, K.; Scheithauer, S.; Merz, U.; Häusler, M. Intrathecal synthesis of anti-viral antibodies in pediatric patients. Eur. J. Paediatr. Neurol., 2007, 11, 29-34.
144. Mancuso, R.; Delbue, S.; Borghi, E.; Pagani, E.; Calvo, M.G.; Caputo, D.; Granieri, E.; Ferrante, P. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J. Med. Virol., 2007, 79, 192-199.
145. Martin, C.; Enbom, M.; Soderstrom, M.; Fredrikson, S.; Dahl, H.; Lycke, J.; Bergström, T.; Linde, A. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol. Scand., 1997, 95, 280-283.
146. Liedtke, W.; Malessa, R.; Faustmann, P.M.; Eis-Hubinger, A.M. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J. Neurovirol., 1995, 1, 253-258.
147. Soldan, S.S.; Berti, R.; Salem, N.; Secchiero, P.; Flamand, L.; Calabresi, P.A.; Brennan, M.B.; Maloni, H.W.; McFarland, H.F.; Lin, H.C.; Patnaik, M.; Jacobson, S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med., 1997, 3, 1394-1397.
148. Ablashi, D.V.; Lapps, W.; Kaplan, M.; Whitman, J.E.; Richert, J.R.; Pearson, G.R. Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult. Scler., 1998, 4, 490-496.
149. Enbom, M.; Wang, F.Z.; Fredrikson, S.; Martin, C.; Dahl, H.; Linde, A. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin. Diagn. Lab. Immunol., 1999, 6, 545-549.
150. Ablashi, D.V.; Eastman, H.B.; Owen, C.B.; Roman, M.M.; Friedman, J.; Zabriskie, J.B.; Peterson, D.L.; Pearson, G.R.; Whitman, J.E. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol., 2000, 16, 179-191.
151. Taus, C.; Pucci, E.; Cartechini, E.; Fie, A.; Giuliani, G.; Clementi, M.; Menzo, S. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol. Scand., 2000, 101, 224-228.
152. Derfuss, T.; Hohlfeld, R.; Meinl, E. Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J. Neurol., 2005, 252, 968-971.
153. Virtanen, J.O.; Farkkila, M.; Multanen, J.; Uotila, L.; Jaaskelainen, A.J.; Vaheri, A.; Koskiniemi, M. Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications. J. Neurovirol., 2007, 13, 347-352.
154. Kuusisto, H.; Hyoty, H.; Kares, S.; Kinnunen, E.; Elovaara, I. Human herpes virus 6 and multiple sclerosis: a Finnish twin study. Mult. Scler., 2008, 14, 54-58.
155. Behzad-Behbahani, A.; Mikaeili, M.H.; Entezam, M.; Mojiri, A.; Pour, G.Y.; Arasteh, M.M.; Rahsaz, M.; Banihashemi, M.; Khadang, B.; Moaddeb, A.; Nematollahi, Z.; Azarpira, N. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J. Microbiol. Immunol. Infect., 2011, 44, 247-251.
156. Enbom, M.; Linde, A.; Evengard, B. No evidence of active infection with human herpesvirus 6 (HHV-6) or HHV-8 in chronic fatigue syndrome. J. Clin. Microbiol., 2000, 38, 2457.
157. Riverol, M.; Sepulcre, J.; Fernandez-Diez, B.; Villoslada, P.; Fernandez-Alonso, M.; Rubio, M.; Rodriguez, A.; Uccelli, A.; Brieva, L. Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis. J. Neuroimmunol., 2007, 192, 184-185.
158. Ongradi, J.; Rajda, C.; Marodi, C.L.; Csiszar, A.; Vecsei, L. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J. Neurovirol., 1999, 5, 529-532.
159. Fillet, A.M.; Lozeron, P.; Agut, H.; Lyon-Caen, O.; Liblau, R. HHV-6 and multiple sclerosis. Nat. Med., 1998, 4, 537; author reply 538.
160. Goldberg, S.H.; Albright, A.V.; Lisak, R.P.; Gonzalez-Scarano, F. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol., 1999, 5, 134-139.
161. Mirandola, P.; Stefan, A.; Brambilla, E.; Campadelli-Fiume, G.; Grimaldi, L.M. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology, 1999, 53, 1367-1368.
162. Tejada-Simon, M.V.; Zang, Y.C.; Hong, J.; Rivera, V.M.; Killian, J.M.; Zhang, J.Z. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J. Virol., 2002, 76, 6147-6154.
163. Al-Shammari, S.; Nelson, R.F.; Voevodin, A. HHV-6 DNAaemia in patients with multiple sclerosis in Kuwait. Acta Neurol. Scand., 2003, 107, 122-124.
164. Alvarez-Lafuente, R.; De Las Heras, V.; Bartolome, M.; Garcia-Montojo, M.; Arroyo, R. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol., 2006, 16, 20-27.
165. Ahram, M.; El-Omar, A.; Baho, Y.; Lubad, M.A. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol. Scand., 2009, 120, 430-435.
166. Torelli, G.; Barozzi, P.; Marasca, R.; Cocconcelli, P.; Merelli, E.; Ceccherini-Nelli, L.; Ferrari, S.; Luppi, M. Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J. Med. Virol., 1995, 46, 178-188.
167. Merelli, E.; Bedin, R.; Sola, P.; Barozzi, P.; Mancardi, G.L.; Ficarra, G.; Franchini, G. Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children. J. Neurol., 1997, 244, 450-454.
168. Mayne, M.; Krishnan, J.; Metz, L.; Nath, A.; Auty, A.; Sahai, B.M.; Power, C. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann. Neurol., 1998, 44, 391-394.
169. Rotola, A.; Cassai, E.; Tola, M.R.; Granieri, E.; Di Luca, D. Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 1999, 67, 529-531.
170. Kim, J.S.; Lee, K.S.; Park, J.H.; Kim, M.Y.; Shin, W.S. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. Eur. Neurol., 2000, 43, 170-173.
171. Rotola, A.; Caselli, E.; Cassai, E.; Tola, M.R.; Granieri, E.; Luca, D.D. Novel human herpesviruses and multiple sclerosis. J. Neurovirol., 2000, 6(Suppl 2), S88-S891.
172. Alvarez-Lafuente, R.; Martin-Estefania, C.; de las Heras, V.; Castrillo, C.; Cour, I.; Picazo, J.J.; Varela De Seijas, E.; Arroyo, R. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol. Scand., 2002, 105, 95-99.
173. Alvarez-Lafuente, R.; Martin-Estefania, C.; de Las Heras, V.; Castrillo, C.; Picazo, J.J.; Varela de Seijas, E.; González, R.A. Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch. Neurol., 2002, 59, 929-933.
174. Alvarez-Lafuente, R.; de las Heras, V.; Garcia-Montojo, M.; Bartolome, M.; Arroyo, R. Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive. Mult. Scler., 2007, 13, 578-583.
175. Cirone, M.; Cuomo, L.; Zompetta, C.; Ruggieri, S.; Frati, L.; Faggioni, A.; Ragona, G. Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens. J. Med. Virol., 2002, 68, 268-272.
176. Mancuso, R.; Hernis, A.; Cavarretta, R.; Caputo, D.; Calabrese, E.; Nemni, R.; Ferrante, P.; Delbue, S.; Clerici, M. Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis. J. Med. Virol., 2010, 82, 1051-1057.